Dr. Emilio Mazza Jr., MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 141 Route 70 E Ste B, Marlton, NJ 08053 Phone: 856-596-9057 Fax: 856-596-0837 |
Ryan J Townsend, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 141 Route 70 E Ste 70, Marlton, NJ 08053 Phone: 856-596-9057 |
Donald Auerbach, M.D Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 750 Rt 73 South, Suite 401, Marlton, NJ 08053 Phone: 856-375-1288 Fax: 856-375-2325 |
Dr. Eric S Sztejman, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 141 Route 70 E Ste B, Marlton, NJ 08053 Phone: 856-596-9057 Fax: 856-596-0837 |
Dr. Mark P. Weir, MB CHB Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 141 Route 70 E Ste B, Marlton, NJ 08053 Phone: 856-596-9057 |
Dr. Jonathan Galli, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 141 Route 70 E Ste B, Marlton, NJ 08053 Phone: 856-596-9057 Fax: 856-596-0837 |
Dr. Rohit Malik, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 141 Route 73 S Ste B, Marlton, NJ 08053 Phone: 856-596-9057 Fax: 856-596-0837 |
Andrew Lee, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 141 Route 70 E Ste B, Marlton, NJ 08053 Phone: 856-596-9057 Fax: 856-596-0837 |
Dr. Thomas Rone Nugent, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 406 Lippincott Dr Ste Ee, Marlton, NJ 08053 Phone: 856-267-0800 Fax: 856-267-0806 |
Dr. Roman Krol, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 141 Route 70 E Ste B, Marlton, NJ 08053 Phone: 856-596-9057 Fax: 856-596-0837 |
Fusun L. Dikengil, M.D. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 141 Route 70 E Ste B, Marlton, NJ 08053 Phone: 856-596-9057 |
John Bermingham, DO Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 750 Rt 73 S, Suite 401, Marlton, NJ 08053 Phone: 856-375-1288 Fax: 856-375-2325 |
Allen Jay Salm, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 141 Route 70 E Ste B, Marlton, NJ 08053 Phone: 856-596-9057 Fax: 856-596-0837 |
Dr. Patrick Mulhall, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 301 Lippincott Dr Ste 410, Marlton, NJ 08053 Phone: 856-355-0340 |
News Archive
Heart defects are the most common type of birth defect, and can be caused by mutations in the gene CHD4. Researchers at the UNC School of Medicine have now revealed key molecular details of how CHD4 mutations lead to heart defects.
biocrea, a biopharmaceutical company focusing on novel treatments for disorders of the central nervous system (CNS), today reported details on the design and synthesis of novel, brain-penetrating phosphodiesterase-10 (PDE10) inhibitors developed in collaboration with Pfizer Inc. (NYSE: PFE). The data were featured in joint presentations1 with Pfizer at the recent 241st ACS National Meeting & Exposition, an event organized by the American Chemical Society (ACS).
EMD Millipore, the Life Science division of Merck KGaA of Germany, today opened its state-of-the-art Biopharmaceutical Technical and Training Center in Shanghai, China. The 28,000 square foot facility will provide support, training and validation services to EMD Millipore's biopharmaceutical customers with operations in China.
In the face of a multipronged front to drive blood pressure up, including a high-salt diet, females are better able to keep their pressure down by increasing levels of a T cell that selectively dials back inflammation, scientists say.
Amerigroup Corporation today announced that net income for the third quarter of 2011 was $48.1 million, or $0.96 per diluted share, versus net income of $84.3 million, or $1.68 per diluted share, for the third quarter of 2010 and compared to $44.3 million, or $0.83 per diluted share, for the second quarter of 2011.
› Verified 6 days ago